Browsing: Pharma

In a whirlwind seven-month period in 2022, Bristol-Myers Squibb received FDA approval for three new…

Issues at the former Catalent plant, now owned by Novo Nordisk, derailed another FDA application,…

Ipsen is halting sales of its cancer drug Tazveric, which it acquired through its acquisition…

Dr. Alan J. Balch, CEO, Patient Advocacy Foundation | Incoming Executive Chairman of the Patient…

Big drug companies are aligning with President Donald Trump’s “most-favored-nation” (MFN) drug pricing policy, but…

Less than two weeks after Pfizer signed a deal with a Chinese pharmaceutical company to…

Servier, run by a nonprofit group, continues to make money with its IDH-mutant glioma treatment…

Kyowa Kirin has decided to halt all clinical development of its OX40 drug following the…

The design of modern research and development labs may need to be rethought. Artificial intelligence…

Outstanding trial results for the combination of Tekvayli and Darzalex Faspro in previously treated relapsed…